tiprankstipranks
Trending News
More News >
EuroEyes International Eye Clinic Limited (HK:1846)
:1846
Hong Kong Market
Advertisement

EuroEyes International Eye Clinic Limited (1846) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

EuroEyes International Eye Clinic Limited has a market cap or net worth of HK$988.10M. The enterprise value is HK$511.91M.
Market CapHK$988.10M
Enterprise ValueHK$511.91M

Share Statistics

EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding320,706,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

EuroEyes International Eye Clinic Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.09%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.09%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee2.22M
Profits Per Employee392.75K
Employee Count322
Asset Turnover0.45
Inventory Turnover24.85

Valuation Ratios

The current PE Ratio of EuroEyes International Eye Clinic Limited is 13.1. EuroEyes International Eye Clinic Limited’s PEG ratio is -0.42.
PE Ratio13.1
PS Ratio1.82
PB Ratio1.19
Price to Fair Value1.19
Price to FCF11.11
Price to Operating Cash Flow9.86
PEG Ratio-0.42

Income Statement

In the last 12 months, EuroEyes International Eye Clinic Limited had revenue of 715.68M and earned 82.28M in profits. Earnings per share was 0.25.
Revenue715.68M
Gross Profit286.59M
Operating Income115.78M
Pretax Income126.47M
Net Income82.28M
EBITDA141.89M
Earnings Per Share (EPS)0.25

Cash Flow

In the last 12 months, operating cash flow was 196.36M and capital expenditures -64.91M, giving a free cash flow of 131.44M billion.
Operating Cash Flow196.36M
Free Cash Flow131.44M
Free Cash Flow per Share0.41

Dividends & Yields

EuroEyes International Eye Clinic Limited pays an annual dividend of HK$0.032, resulting in a dividend yield of 2.01%
Dividend Per ShareHK$0.032
Dividend Yield2.01%
Payout Ratio13.29%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.25
52-Week Price Change-35.32%
50-Day Moving Average3.14
200-Day Moving Average3.13
Relative Strength Index (RSI)44.07
Average Volume (3m)199.35K

Important Dates

EuroEyes International Eye Clinic Limited upcoming earnings date is Apr 1, 2026, TBA (Not Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend DateSep 26, 2025

Financial Position

EuroEyes International Eye Clinic Limited as a current ratio of 4.69, with Debt / Equity ratio of 29.21%
Current Ratio4.69
Quick Ratio4.58
Debt to Market Cap<0.01
Net Debt to EBITDA-2.35
Interest Coverage Ratio0.00

Taxes

In the past 12 months, EuroEyes International Eye Clinic Limited has paid 42.11M in taxes.
Income Tax42.11M
Effective Tax Rate0.33

Enterprise Valuation

EuroEyes International Eye Clinic Limited EV to EBITDA ratio is 6.84, with an EV/FCF ratio of 8.27.
EV to Sales1.36
EV to EBITDA6.84
EV to Free Cash Flow8.27
EV to Operating Cash Flow4.91

Balance Sheet

EuroEyes International Eye Clinic Limited has HK$769.46M in cash and marketable securities with HK$345.45M in debt, giving a net cash position of HK$424.01M billion.
Cash & Marketable SecuritiesHK$769.46M
Total DebtHK$345.45M
Net CashHK$424.01M
Net Cash Per ShareHK$1.32
Tangible Book Value Per ShareHK$2.55

Margins

Gross margin is 40.04%, with operating margin of 16.18%, and net profit margin of 11.50%.
Gross Margin40.04%
Operating Margin16.18%
Pretax Margin17.67%
Net Profit Margin11.50%
EBITDA Margin19.83%
EBIT Margin14.63%

Analyst Forecast

The average price target for EuroEyes International Eye Clinic Limited is HK$3.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$3.50
Price Target Upside15.13% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-1.61%
EPS Growth Forecast-27.39%

Scores

Smart Score4
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis